United States · Business magazines · Quartz
Denmark's Leo Pharma is pushing its IPO plans past 2026 on market volatility

Detailed summary
CEO Christophe Bourdon said Leo Pharma's owners see market conditions as unsuitable and declined to give a new timeline
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)




